Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT06183957
Eligibility Criteria:
Inclusion Criteria:
* -Voluntarily agreeing to participate in the study
* She will have her second birth spontaneously vaginally at term (between 37-42 weeks of pregnancy).
* The fetal weight estimated by ultrasound is 2500-4000 grams
* Single fetus and head presentation
* Being in the active phase of labor (cervical dilation 4 cm)
* Ability to establish written/verbal communication
* Not taking any analgesia or anesthesia to relieve pain and fatigue before birth and during labor.
* Newborn APGAR score is 7 or above
Exclusion Criteria:
* giving up on research
* Having received infertility treatment
* Birth by cesarean section
* Having an interventional birth (forceps, vacuum, episiotomy application)
* Being primiparous, having a third or more birth (grandmultiparous)
* Having any systemic, chronic and neurological disease (Diabetes Mellitus, Hypertension, Thyroid diseases, Multiple Sclerosis, Epilepsy, etc.)
* Regular use of medication due to any disease
* Receiving psychiatric treatment (pharmacotherapy/psychotherapy)
* Any induction application that will affect uterine contractions and dilation
* Having any pregnancy complications (placenta previa, preeclampsia, premature rupture of membranes, oligohydramnios and polyhydramnios, contraction anomalies, presentation disorder, intrauterine growth retardation, intrauterine dead fetus, macrosomic babies, fetal distress, etc.)
* Having any problem that prevents communication (such as not knowing Turkish, hearing, speaking and understanding impairment),
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
20 Years
Maximum Age:
35 Years
Study:
NCT06183957
Study Brief:
Protocol Section:
NCT06183957